Tags

Type your tag names separated by a space and hit enter

Mapping the entire functionally active endometrial microbiota.
Hum Reprod. 2021 03 18; 36(4):1021-1031.HR

Abstract

STUDY QUESTION

Does endometrium harbour functionally active microorganisms and whether the microbial composition differs between proliferative and mid-secretory phases?

SUMMARY ANSWER

Endometrium harbours functionally alive microorganisms including bacteria, viruses, archaea and fungi whose composition and metabolic functions change along the menstrual cycle.

WHAT IS KNOWN ALREADY

Resident microbes in the endometrium have been detected, where microbial dysfunction has been associated with reproductive health and disease. Nevertheless, the core microorganismal composition in healthy endometrium is not determined and whether the identified bacterial DNA sequences refer to alive/functionally active microbes is not clear. Furthermore, whether there are cyclical changes in the microbial composition remains an open issue.

STUDY DESIGN, SIZE, DURATION

RNA sequencing (RNAseq) data from 14 endometrial paired samples from healthy women, 7 samples from the mid-secretory phase and 7 samples from the consecutive proliferative phase were analysed for the microbial RNA sequences.

PARTICIPANTS/MATERIALS, SETTING, METHODS

The raw RNAseq data were converted into FASTQ format using SRA Toolkit. The unmapped reads to human sequences were aligned to the reference database Kraken2 and visualised with Krona software. Menstrual phase taxonomic differences were performed by R package metagenomeSeq. The functional analysis of endometrial microbiota was obtained with HUMANn2 and the comparison between menstrual phases was conducted by one-way ANOVA. Human RNAseq analysis was performed using miARma-Seq and the functional enrichment analysis was carried out using gene set enrichment analysis (GSEA; HumanCyc). The integration of metabolic pathways between host and microbes was investigated. The developed method of active microbiota mapping was validated in independent sample set.

MAIN RESULTS AND THE ROLE OF CHANCE

With the novel metatranscriptomic approach, we mapped the entire alive microbiota composing of >5300 microorganisms within the endometrium of healthy women. Microbes such as bacteria, fungi, viruses and archaea were identified. The validation of three independent endometrial samples from different ethnicity confirmed the findings. Significant differences in the microbial abundances in the mid-secretory vs. proliferative phases were detected with possible metabolic activity in the host-microbiota crosstalk in receptive phase endometrium, specifically in the prostanoid biosynthesis pathway and L-tryptophan metabolism.

LARGE SCALE DATA

The raw RNAseq data used in the current study are available at GEO GSE86491 and at BioProject PRJNA379542.

LIMITATIONS, REASONS FOR CAUTION

These pioneering results should be confirmed in a bigger sample size.

WIDER IMPLICATIONS OF THE FINDINGS

Our study confirms the presence of active microbes, bacteria, fungi, viruses and archaea in the healthy human endometrium with implications in receptive phase endometrial functions, meaning that microbial dysfunction could impair the metabolic pathways important for endometrial receptivity. The results of this study contribute to the better understanding of endometrial microbiota composition in healthy women and its possible role in endometrial functions. In addition, our novel methodological pipeline for analysing alive microbes with transcriptional and metabolic activities could serve to inspire new analysis approaches in reproductive medicine.

STUDY FUNDING/COMPETING INTERESTS

This work is supported by the Spanish Ministry of Economy, Industry and Competitiveness (MINECO) and European Regional Development Fund (FEDER): grants RYC-2016-21199 and ENDORE SAF2017-87526-R; FEDER/Junta de Andalucía-Consejería de Economía y Conocimiento: MENDO (B-CTS-500-UGR18) and by the University of Granada Plan Propio de Investigación 2016 - Excellence actions: Unit of Excellence on Exercise and Health (UCEES) (SOMM17/6107/UGR). A.S.-L. and N.M.M. are funded by the Spanish Ministry of Science, Innovation and Universities (PRE2018-0854409 and FPU19/01638). S.A. has received honoraria for lectures from Merck. The funder had no role in this study.

Authors+Show Affiliations

Department of Biochemistry and Molecular Biology, Faculty of Sciences, University of Granada, Granada 18071, Spain. Instituto de Investigación Biosanitaria ibs.GRANADA, Granada 18014, Spain.Unidad de Bioinformática, Instituto de Parasitología y Biomedicina "López-Neyra", CSIC (IPBLN-CSIC), Granada 18016, Spain.Department of Biochemistry and Molecular Biology, Faculty of Sciences, University of Granada, Granada 18071, Spain. Instituto de Investigación Biosanitaria ibs.GRANADA, Granada 18014, Spain.Unidad de Bioinformática, Instituto de Parasitología y Biomedicina "López-Neyra", CSIC (IPBLN-CSIC), Granada 18016, Spain.Instituto de Investigación Biosanitaria ibs.GRANADA, Granada 18014, Spain. Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, University of Granada, Granada 18071, Spain. Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, Canada.Department of Biochemistry and Molecular Biology, Faculty of Sciences, University of Granada, Granada 18071, Spain. Instituto de Investigación Biosanitaria ibs.GRANADA, Granada 18014, Spain. Institute of Nutrition and Food Technology (INYTA), "José Mataix Verdú" Biomedical Research Centre (CIBM), University of Granada, Armilla, Granada 18016, Spain.Instituto de Investigación Biosanitaria ibs.GRANADA, Granada 18014, Spain. Unidad Reproducción, UGC Laboratorio clínico y UGC Obstetricia y Ginecología. Hospital Universitario Virgen de las Nieves, Granada 18014, Spain.Instituto de Investigación Biosanitaria ibs.GRANADA, Granada 18014, Spain. Unidad Reproducción, UGC Laboratorio clínico y UGC Obstetricia y Ginecología. Hospital Universitario Virgen de las Nieves, Granada 18014, Spain.Instituto de Investigación Biosanitaria ibs.GRANADA, Granada 18014, Spain. Unidad Reproducción, UGC Laboratorio clínico y UGC Obstetricia y Ginecología. Hospital Universitario Virgen de las Nieves, Granada 18014, Spain.Instituto de Investigación Biosanitaria ibs.GRANADA, Granada 18014, Spain. Unidad Reproducción, UGC Laboratorio clínico y UGC Obstetricia y Ginecología. Hospital Universitario Virgen de las Nieves, Granada 18014, Spain.Department of Biochemistry and Molecular Biology, Faculty of Sciences, University of Granada, Granada 18071, Spain. Instituto de Investigación Biosanitaria ibs.GRANADA, Granada 18014, Spain. Competence Centre on Health Technologies, Tartu 50411, Estonia.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

33598714

Citation

Sola-Leyva, Alberto, et al. "Mapping the Entire Functionally Active Endometrial Microbiota." Human Reproduction (Oxford, England), vol. 36, no. 4, 2021, pp. 1021-1031.
Sola-Leyva A, Andrés-León E, Molina NM, et al. Mapping the entire functionally active endometrial microbiota. Hum Reprod. 2021;36(4):1021-1031.
Sola-Leyva, A., Andrés-León, E., Molina, N. M., Terron-Camero, L. C., Plaza-Díaz, J., Sáez-Lara, M. J., Gonzalvo, M. C., Sánchez, R., Ruíz, S., Martínez, L., & Altmäe, S. (2021). Mapping the entire functionally active endometrial microbiota. Human Reproduction (Oxford, England), 36(4), 1021-1031. https://doi.org/10.1093/humrep/deaa372
Sola-Leyva A, et al. Mapping the Entire Functionally Active Endometrial Microbiota. Hum Reprod. 2021 03 18;36(4):1021-1031. PubMed PMID: 33598714.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Mapping the entire functionally active endometrial microbiota. AU - Sola-Leyva,Alberto, AU - Andrés-León,Eduardo, AU - Molina,Nerea M, AU - Terron-Camero,Laura Carmen, AU - Plaza-Díaz,Julio, AU - Sáez-Lara,María José, AU - Gonzalvo,María Carmen, AU - Sánchez,Rocío, AU - Ruíz,Susana, AU - Martínez,Luís, AU - Altmäe,Signe, PY - 2020/07/03/received PY - 2020/12/11/revised PY - 2021/2/19/pubmed PY - 2021/5/29/medline PY - 2021/2/18/entrez KW - endometrium KW - menstrual cycle KW - metabolism KW - microbiome KW - microbiota SP - 1021 EP - 1031 JF - Human reproduction (Oxford, England) JO - Hum Reprod VL - 36 IS - 4 N2 - STUDY QUESTION: Does endometrium harbour functionally active microorganisms and whether the microbial composition differs between proliferative and mid-secretory phases? SUMMARY ANSWER: Endometrium harbours functionally alive microorganisms including bacteria, viruses, archaea and fungi whose composition and metabolic functions change along the menstrual cycle. WHAT IS KNOWN ALREADY: Resident microbes in the endometrium have been detected, where microbial dysfunction has been associated with reproductive health and disease. Nevertheless, the core microorganismal composition in healthy endometrium is not determined and whether the identified bacterial DNA sequences refer to alive/functionally active microbes is not clear. Furthermore, whether there are cyclical changes in the microbial composition remains an open issue. STUDY DESIGN, SIZE, DURATION: RNA sequencing (RNAseq) data from 14 endometrial paired samples from healthy women, 7 samples from the mid-secretory phase and 7 samples from the consecutive proliferative phase were analysed for the microbial RNA sequences. PARTICIPANTS/MATERIALS, SETTING, METHODS: The raw RNAseq data were converted into FASTQ format using SRA Toolkit. The unmapped reads to human sequences were aligned to the reference database Kraken2 and visualised with Krona software. Menstrual phase taxonomic differences were performed by R package metagenomeSeq. The functional analysis of endometrial microbiota was obtained with HUMANn2 and the comparison between menstrual phases was conducted by one-way ANOVA. Human RNAseq analysis was performed using miARma-Seq and the functional enrichment analysis was carried out using gene set enrichment analysis (GSEA; HumanCyc). The integration of metabolic pathways between host and microbes was investigated. The developed method of active microbiota mapping was validated in independent sample set. MAIN RESULTS AND THE ROLE OF CHANCE: With the novel metatranscriptomic approach, we mapped the entire alive microbiota composing of >5300 microorganisms within the endometrium of healthy women. Microbes such as bacteria, fungi, viruses and archaea were identified. The validation of three independent endometrial samples from different ethnicity confirmed the findings. Significant differences in the microbial abundances in the mid-secretory vs. proliferative phases were detected with possible metabolic activity in the host-microbiota crosstalk in receptive phase endometrium, specifically in the prostanoid biosynthesis pathway and L-tryptophan metabolism. LARGE SCALE DATA: The raw RNAseq data used in the current study are available at GEO GSE86491 and at BioProject PRJNA379542. LIMITATIONS, REASONS FOR CAUTION: These pioneering results should be confirmed in a bigger sample size. WIDER IMPLICATIONS OF THE FINDINGS: Our study confirms the presence of active microbes, bacteria, fungi, viruses and archaea in the healthy human endometrium with implications in receptive phase endometrial functions, meaning that microbial dysfunction could impair the metabolic pathways important for endometrial receptivity. The results of this study contribute to the better understanding of endometrial microbiota composition in healthy women and its possible role in endometrial functions. In addition, our novel methodological pipeline for analysing alive microbes with transcriptional and metabolic activities could serve to inspire new analysis approaches in reproductive medicine. STUDY FUNDING/COMPETING INTERESTS: This work is supported by the Spanish Ministry of Economy, Industry and Competitiveness (MINECO) and European Regional Development Fund (FEDER): grants RYC-2016-21199 and ENDORE SAF2017-87526-R; FEDER/Junta de Andalucía-Consejería de Economía y Conocimiento: MENDO (B-CTS-500-UGR18) and by the University of Granada Plan Propio de Investigación 2016 - Excellence actions: Unit of Excellence on Exercise and Health (UCEES) (SOMM17/6107/UGR). A.S.-L. and N.M.M. are funded by the Spanish Ministry of Science, Innovation and Universities (PRE2018-0854409 and FPU19/01638). S.A. has received honoraria for lectures from Merck. The funder had no role in this study. SN - 1460-2350 UR - https://www.unboundmedicine.com/medline/citation/33598714/Mapping_the_entire_functionally_active_endometrial_microbiota_ DB - PRIME DP - Unbound Medicine ER -